E-DRUG: Venezuela WTO proposal on Essential Drugs
---------------------------------------------------------------------
[copied from PHARM-POLICY; WB]
This is the Venezuela proposal on essential drugs and TRIPS.
Jamie
WT/GC/W/282
PREPARATIONS FOR THE 1999 MINISTERIAL CONFERENCE
Proposals Regarding the TRIPS Agreement
(Paragraph 9(a)(ii) of the Geneva Ministerial Declaration)
Communication from Venezuela
II. REVIEW OF THE TRIPS AGREEMENT IN THE YEAR 2000
The TRIPS Agreement itself is delicately poised between rights and
obligations in various areas of intellectual property. However, there
are many aspects and areas of interest to the developing and
least-developed countries which are left unregulated by the final text
of the Agreement. In this connection, it is important to begin a full
review and possible renegotiation of the TRIPS Agreement from the
development standpoint, taking into account the scope and
interpretation which should be given to special and differential
treatment and the identification of the policy areas necessary for the
achievement of this objective. Venezuela considers that, among other
things, a review should involve the following:
[snip]
3. Extend the list of exceptions to patentability in Article 27.3(b) of
the TRIPSAgreement to include the list of essential drugs of the World
Health Organization, in order to develop the principles established in
Article 8 of the Agreement.
--
James Love / Director, Consumer Project on Technology
http://www.cptech.org / love@cptech.org
P.O. Box 19367, Washington, DC 20036
voice 202.387.8030 / fax 202.234.5176
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.